An image of rising and declining prices
Markets

Pfizer’s Q3 Profit Plunges 70% on Charges; Adjusted Net Beats View (PFE)

Pharmaceutical giant Pfizer Inc. ( PFE ) on Tuesday said its third quarter profit slipped 70% from last year on one-time charges, but adjusted profits beat analyst expectations.

The New York-based company reported third quarter net income of $866 million, or 11 cents per share, compared with $2.88 billion, or 43 cents per share, in the year-ago period. Excluding one-time items, adjusted profit was 54 cents per share.

Revenue jumped 39% from last year to $16.17 billion, aided mainly by the company's recent acquisition of rival pharma giant Wyeth.

On average, Wall Street analysts expected a smaller adjusted profit of 51 cents per share, albeit on higher revenue of $16.68 billion.

Looking ahead, the company boosted its full-year 2010 earnings forecast to a range of $2.17 to $2.22 per share, up from a prior estimate of $2.10 to $2.20. Analysts currently expect $2.22 per share for the year.

Pfizer shares were mostly flat in premarket trading Tuesday.

The Bottom Line

Shares of PFE have a 4.09% dividend yield, based on last night's closing stock price of $17.62. The stock has technical support in the $15-$17 price area. If the shares can firm up, we see overhead resistance around the $19-$20 price levels. We would remain on the sidelines for now.

Pfizer Inc. ( PFE ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE

Other Topics

Stocks